Q/C Technologies Inc. Company Profile
NASDAQ: QCLSHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
Market open · Delayed 15 min · as of Oct 9, 10:59 AM ET
Q/C Technologies at a glance
Q/C Technologies Inc. (NASDAQ: QCLS) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company in the Health Care sector headquartered in New York, NY. Q/C Technologies employs about 3 people. The company's shares have traded publicly since 2014.
At a market capitalization of $5.2 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001321834, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Q/C Technologies do?
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. In addition, it is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications;. The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Q/C Technologies Inc.
- Ticker
- NASDAQ: QCLS
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Employees
- 3
- Headquarters
- 1185 Avenue of the Americas, New York, NY, United States
- Phone
- 856 848 8698
- Website
- qctechnologies.com
- IPO year
- 2014
- Market cap
- $5.18M
- SEC CIK
- 0001321834
Companies similar to Q/C Technologies
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TRIBTrinity Biotech plc ADR | 6.39 | +5.71% | $5.19M | vs QCLS |
| CDIOCardio Diagnostics Holdings Inc. | 1.91 | +2.51% | $5.65M | vs QCLS |
| VNRXVolitionRX Limited | 0.2273 | +3.56% | $6.83M | vs QCLS |
| VRAXVirax Biolabs Group Limited | 1.85 | -7.04% | $2.49M | vs QCLS |
| BMRABiomerica Inc. | 1.86 | -0.53% | $8.55M | vs QCLS |
| ICCCImmuCell Corporation | 9.75 | 0.00% | $88.55M | vs QCLS |
| IMDXInsight Molecular Diagnostics Inc. | 3.32 | +1.22% | $108.64M | vs QCLS |
| NNNNAnbio Biotechnology Class A | 4.48 | -3.03% | $196.63M | vs QCLS |